This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Kayexalate (Sodium Polystyrene Sulfonate) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (58)
Death (2)
Life Threatening Events (13)
Disability (1)
Reports by Reaction Type
Thrombocytopenia (12),
Anaemia (12),
Renal Impairment (12),
Tubulointerstitial Nephritis (8),
Dizziness (8),
Nephropathy (8),
Hypokalaemia (6),
Condition Aggravated (6),
Hydrocephalus (5),
Cardiomyopathy (5),
Lung Disorder (5),
Sepsis (5)
Below are a few examples of reports where side effects / adverse reactions may be related to Kayexalate (Sodium Polystyrene Sulfonate). For a complete list or a specific selection of reports, please use the links above.
Possible Kayexalate side effects in 82 year old female
Reported by a physician from France on 2012-08-21
Patient: 82 year old female
Reactions: Death, Hyperkalaemia, Hypokalaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ixabepilone
Start date: 2010-06-02
End date: 2011-12-14
Kayexalate
Possible Kayexalate side effects in 82 year old female
Reported by a physician from France on 2012-08-07
Patient: 82 year old female
Reactions: Hyperkalaemia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kayexalate
Ixabepilone
Start date: 2010-06-02
End date: 2011-12-14
Possible Kayexalate side effects in
Reported by a individual with unspecified qualification from United States on 2012-07-17
Patient:
Reactions: Circumstance or Information Capable of Leading To Medication Error
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kayexalate
Possible Kayexalate side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-08
Patient: 56 year old male, weighing 92.0 kg (202.4 pounds)
Reactions: Condition Aggravated, Cardiomyopathy, Bladder Cancer, Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Fenofibrate
Administration route: Oral
Indication: Hypertriglyceridaemia
Januvia
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Aspirin
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Diamicron
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Bisoprolol Fumarate
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Kayexalate
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Minirin
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Perindopril Erbumine
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Actos
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Prazosin HCL
Indication: Hypertension
End date: 2010-02-01
Allopurinol
Administration route: Oral
Indication: Hyperuricaemia
Possible Kayexalate side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29
Patient: 56 year old male, weighing 92.0 kg (202.4 pounds)
Reactions: Bladder Cancer
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Diamicron
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Bisoprolol Fumarate
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Aspirin
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Prazosin HCL
Indication: Hypertension
End date: 2010-02-01
Actos
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Minirin
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Fenofibrate
Administration route: Oral
Indication: Hypertriglyceridaemia
Kayexalate
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Januvia
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Allopurinol
Administration route: Oral
Indication: Hyperuricaemia
Perindopril Erbumine
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Possible Kayexalate side effects in male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-25
Patient: male
Reactions: Anaemia, Condition Aggravated, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Dosage: 1 df
Administration route: Oral
Start date: 2011-05-01
Renagel
Dosage: 1 df
Administration route: Oral
Aranesp
Dosage: 0.0667 df
Calciparine
Start date: 2011-07-08
End date: 2011-08-08
Citalopram Hydrobromide
Administration route: Oral
Depakene
Dosage: 2 df
Administration route: Oral
Start date: 2011-07-16
Eupressyl
Dosage: 3 df
Administration route: Oral
Start date: 2011-05-29
Kayexalate
Dosage: 0.4286 df
Start date: 2011-06-03
Calcium Carbonate
Administration route: Oral
Other drugs received by patient: Levetiracetam
Possible Kayexalate side effects in 80 year old male
Reported by a physician from United States on 2012-05-15
Patient: 80 year old male
Reactions: Rectal Haemorrhage, Gastrointestinal Mucosal Necrosis, Ulcer, Faeces Discoloured, Haemoglobin Decreased, Haematocrit Decreased, Bacteraemia, Injury, Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kayexalate
Other drugs received by patient: Insulin; Dextrose 5%; Sorbitol 50pc INJ
Possible Kayexalate side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-19
Patient: 56 year old male
Reactions: Bladder Transitional Cell Carcinoma Stage II, Cardiomyopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Diamicron (Gliclazide)
Dosage: 30 mg, qd, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Perindopril Erbumine
Dosage: 2.5 mg
Start date: 2009-12-01
Aceon
Dosage: 2.5 mg,qd,oral
Administration route: Oral
Bisoprolol Fumarate
Dosage: 2.5 mg, qd, oral
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Allopurinol
Dosage: 300 mg, qd, oral
Administration route: Oral
Indication: Hyperuricaemia
Fenofibrate
Dosage: 200 mg, qd, oral
Administration route: Oral
Indication: Hypertriglyceridaemia
Januvia
Dosage: 100 mg, qd, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Kayexalate
Dosage: 1 unit every 2 weeks, oral
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Aspirin
Dosage: 75 mg, qd, oral
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Actos
Dosage: 30 mg, qd, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Minirin
Dosage: 100 ug, tid, oral
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Prazosin HCL
Dosage: 5 mg, qd, oral
Administration route: Oral
Indication: Hypertension
End date: 2010-02-01
Possible Kayexalate side effects in 56 year old male
Reported by a individual with unspecified qualification from France on 2012-03-13
Patient: 56 year old male
Reactions: Condition Aggravated, Cardiomyopathy, Bladder Transitional Cell Carcinoma Stage II, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Fenofibrate
Dosage: 200 mg, before 2006, oral
Administration route: Oral
Indication: Hypertriglyceridaemia
Start date: 2006-01-01
Diamicron (Gliclazide) Tablet 30 MG
Dosage: 30 mg, before 2006, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-01-01
Allopurinol
Dosage: 300 mg, before 2006, oral
Administration route: Oral
Indication: Hyperuricaemia
Start date: 2006-01-01
Januvia
Dosage: 100 mg, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Actos
Dosage: 30 mg, oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Perindopril Erbumine
Dosage: 2.5 mg, oral
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Aspirin
Dosage: 75 mg, oral
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Bisoprolol Fumarate
Dosage: 2.5 mg, oral
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Desmopressin Acetate
Dosage: 300 ug, oral
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Prazosin HCL
Dosage: oral
Administration route: Oral
Indication: Hypertension
Start date: 2006-01-01
End date: 2010-02-01
Kayexalate
Dosage: oral
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Possible Kayexalate side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-12
Patient: 34 year old female
Reactions: Dialysis, Maternal Exposure During Pregnancy, Cervix Disorder, Foetal Death, Uterine Contractions During Pregnancy, Abortion Spontaneous
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neoral
Dosage: 100 mg, bid : 50 mg, bid : 25 mg, bid
Indication: Product Used FOR Unknown Indication
Start date: 2008-11-05
End date: 2008-12-17
Neoral
Dosage: 100 mg, bid : 50 mg, bid : 25 mg, bid
Indication: Product Used FOR Unknown Indication
End date: 2008-10-21
Neoral
Dosage: 100 mg, bid : 50 mg, bid : 25 mg, bid
Indication: Product Used FOR Unknown Indication
Start date: 2008-10-22
End date: 2008-11-05
Rhinofluimucil (Acetycysteine, Benzalkonium Chloride, Tuaminoheptane)
Dosage: 2 bid
Indication: Product Used FOR Unknown Indication
Start date: 2008-11-07
End date: 2008-11-10
Atarax
Dosage: 25 mg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-18
End date: 2008-12-17
Amlodipine Besylate
Dosage: 5 mg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-20
End date: 2008-09-16
Amlodipine Besylate
Dosage: 5 mg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2008-09-17
End date: 2008-12-15
Venofer
Dosage: 1, 2x/w : 1, 3x/w : 1, 1x/w
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-13
End date: 2008-10-16
Venofer
Dosage: 1, 2x/w : 1, 3x/w : 1, 1x/w
Indication: Product Used FOR Unknown Indication
Start date: 2008-12-15
End date: 2008-12-17
Azathioprine
Dosage: 75 mg, bid : 50 mg, bid : 25 mg
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-13
End date: 2008-08-21
Azathioprine
Dosage: 75 mg, bid : 50 mg, bid : 25 mg
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-22
End date: 2008-09-05
Azathioprine
Dosage: 75 mg, bid : 50 mg, bid : 25 mg
Indication: Product Used FOR Unknown Indication
Start date: 2008-09-06
End date: 2008-09-16
Rubozinc (Zinc Gluconate)
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-29
End date: 2008-09-16
Nexium
Dosage: 40 mg, qd : 20 mg
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-22
End date: 2008-12-17
Nexium
Dosage: 40 mg, qd : 20 mg
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-13
End date: 2008-08-21
Kayexalate
Dosage: 1 , qd : 2 , qd
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-13
End date: 2008-08-04
Kayexalate
Dosage: 1 , qd : 2 , qd
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-05
End date: 2008-11-15
Mucomyst
Dosage: 200 mg, bid
Indication: Product Used FOR Unknown Indication
Start date: 2008-11-07
End date: 2008-11-10
UN-Alfa (Alfacalcidol)
Dosage: 5 mcg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2008-07-04
End date: 2008-10-17
Renagel
Dosage: 800 mg, tid
Indication: Hyperphosphataemia
Start date: 2008-08-28
End date: 2008-12-15
Cefpodoxime Proxetil
Dosage: 100 mg, bid
Indication: Product Used FOR Unknown Indication
Start date: 2008-11-07
End date: 2008-11-17
Aranesp
Dosage: 60 mcg, 1x/w : 80 mcg, 2x/w
Indication: Product Used FOR Unknown Indication
Start date: 2008-09-29
End date: 2008-12-17
Aranesp
Dosage: 60 mcg, 1x/w : 80 mcg, 2x/w
Indication: Product Used FOR Unknown Indication
Start date: 2008-07-27
End date: 2008-09-28
Tixocortol Pivalate
Dosage: 2 bid
Indication: Product Used FOR Unknown Indication
Start date: 2008-10-31
End date: 2008-11-07
Antibiotrex (Erythromycin, Isotretinoin)
Dosage: 1 day, bid
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-29
End date: 2008-09-16
Furosemide
Dosage: 500 mg, bid
Indication: Product Used FOR Unknown Indication
Start date: 2008-06-13
End date: 2008-12-15
Folic Acid
Dosage: 5 mg, bid
Indication: Product Used FOR Unknown Indication
Start date: 2008-10-08
End date: 2008-12-17
Possible Kayexalate side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-09
Patient: male
Reactions: Type 2 Diabetes Mellitus, Bladder Cancer Stage II, Cardiac Failure, Congestive Cardiomyopathy, Cardiomyopathy, Appendicitis, Hyperuricaemia, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Actos
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Allopurinol
Administration route: Oral
Indication: Hyperuricaemia
Aspirin
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Januvia
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Kayexalate
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Prazosin HCL
Administration route: Oral
Indication: Hypertension
End date: 2010-02-01
Diamicron
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2010-03-30
Prazosin HCL
Indication: Congestive Cardiomyopathy
Minirin
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Perindopril Erbumine
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Kayexalate
Indication: Congestive Cardiomyopathy
Bisoprolol Fumarate
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Fenofibrate
Administration route: Oral
Indication: Hypertriglyceridaemia
Other drugs received by patient: Metformin HCL; Victoza
Possible Kayexalate side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-08
Patient: 34 year old female
Reactions: Maternal Exposure During Pregnancy, Foetal Death
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amlodipine Besylate
Dosage: 10 mg, 1x/day
Start date: 2008-09-17
End date: 2008-12-15
Atarax
Dosage: 25 mg, 1x/day
Start date: 2008-08-18
End date: 2008-12-17
Tixocortol Pivalate
Dosage: 2 gtt, 2x/day
Start date: 2008-10-31
End date: 2008-11-07
Kayexalate
Dosage: unk
Start date: 2008-06-13
End date: 2008-08-04
Acetylcysteine
Dosage: unk
Start date: 2008-11-07
End date: 2008-11-10
Nexium
Dosage: 40 mg, 1x/day
Start date: 2008-06-13
End date: 2008-08-21
Amlodipine Besylate
Dosage: 5 mg, 1x/day
Start date: 2008-06-20
End date: 2008-09-16
Isotretinoin
Dosage: unk
Start date: 2008-08-29
End date: 2008-09-16
Lasix
Dosage: 500 mg, 2x/day
Start date: 2008-06-13
End date: 2008-12-15
Folic Acid
Dosage: 5 mg, 2x/day
Start date: 2008-10-08
End date: 2008-12-17
Mucomyst
Dosage: 200 mg, 2x/day
Start date: 2008-11-07
End date: 2008-11-10
Aranesp
Dosage: 60 ug, weekly
Start date: 2008-08-27
End date: 2008-09-28
Imuran
Dosage: 1.5 df, 2x/day
Start date: 2008-06-13
End date: 2008-08-21
Kayexalate
Dosage: unk
Start date: 2008-08-05
End date: 2008-11-15
Cefpodoxime Proxetil
Dosage: 100 mg, 2x/day
Start date: 2008-11-07
End date: 2008-11-17
Imuran
Dosage: 0.5 df, 1x/day
Start date: 2008-09-06
End date: 2008-09-16
Neoral
Dosage: 100 mg, 2x/day
End date: 2008-10-21
Neoral
Dosage: 25 mg, 2x/day
Start date: 2008-11-06
End date: 2008-12-17
Renagel
Dosage: 800 mg, 3x/day
Start date: 2008-08-28
End date: 2008-12-15
UN-Alfa
Dosage: 0.5 ug, 1x/day
Start date: 2008-07-04
End date: 2008-10-17
Venofer
Dosage: 100 ug, tree time x week
Start date: 2008-10-17
End date: 2008-12-14
Imuran
Dosage: 1 df, 2x/day
Start date: 2008-08-22
End date: 2008-09-05
Neoral
Dosage: 50 mg, 2x/day
Start date: 2008-10-22
End date: 2008-11-05
Erythromycin
Dosage: unk
Start date: 2008-08-29
End date: 2008-09-16
Aranesp
Dosage: 80 ug, unk
Start date: 2008-09-29
End date: 2008-12-17
Venofer
Dosage: 100 ug, twice x week
Start date: 2008-06-13
End date: 2008-10-16
Rubozinc
Dosage: 15 mg, 1x/day
Start date: 2008-08-29
End date: 2008-09-16
Nexium
Dosage: 20 mg, 1x/day
Start date: 2008-08-22
End date: 2008-12-17
Venofer
Dosage: 100 ug, twice x week
Start date: 2008-12-15
End date: 2008-12-17
Possible Kayexalate side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07
Patient: 56 year old male
Reactions: Bladder Transitional Cell Carcinoma Stage II
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Actos
Administration route: Oral
Start date: 2006-03-01
End date: 2010-02-01
Diamicron
Administration route: Oral
Metformin HCL
Kayexalate
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Januvia
Administration route: Oral
Start date: 2009-10-01
Allopurinol
Administration route: Oral
Indication: Hyperuricaemia
Perindopril Erbumine
Administration route: Oral
Start date: 2009-12-01
Minirin
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Bisoprolol Fumarate
Administration route: Oral
Start date: 2009-12-01
Aspirin
Administration route: Oral
Start date: 2009-12-01
Prazosin HCL
Administration route: Oral
End date: 2010-02-01
Fenofibrate
Administration route: Oral
Indication: Hypertriglyceridaemia
Possible Kayexalate side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-02
Patient: 56 year old male
Reactions: Bladder Transitional Cell Carcinoma Stage II
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prazosin HCL
Dosage: 5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
End date: 2010-02-01
Bisoprolol Fumarate
Dosage: 2.5 mg, 1x/day
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Januvia
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Diamicron
Dosage: 30 mg, 1x/day
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Perindopril Erbumine
Dosage: 2.5 mg, 1x/day
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Aspirin
Dosage: 75 mg, 1x/day
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Kayexalate
Dosage: 1 df, 2x/week
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Minirin
Dosage: 100 ug, 3x/day
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Actos
Dosage: 30 mg, 1x/day
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Fenofibrate
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Hypertriglyceridaemia
Allopurinol
Dosage: 300 mg, 1x/day
Administration route: Oral
Indication: Hyperuricaemia
Possible Kayexalate side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-02
Patient: male
Reactions: Bladder Cancer Stage II, Cardiac Failure, Cardiomyopathy, Appendicitis, Infectious Peritonitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Diamicron
Administration route: Oral
Indication: Pain
End date: 2010-03-30
Minirin
Administration route: Oral
Indication: Diabetes Insipidus
Start date: 1995-01-01
Actos
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2006-03-01
End date: 2010-02-01
Allopurinol
Administration route: Oral
Indication: Hyperuricaemia
Perindopril Erbumine
Dosage: 100 mcg thrice
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 1999-12-01
Januvia
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-10-01
Prazosin HCL
Administration route: Oral
Indication: Hypertension
End date: 2010-02-01
Bisoprolol Fumarate
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 2009-12-01
Fenofibrate
Administration route: Oral
Indication: Hypertriglyceridaemia
Aspirin
Administration route: Oral
Indication: Congestive Cardiomyopathy
Start date: 1999-12-01
Kayexalate
Administration route: Oral
Indication: Hyperkalaemia
Start date: 2010-05-01
Other drugs received by patient: Victoza; Metformin HCL
Possible Kayexalate side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-01
Patient: 34 year old female
Reactions: Maternal Exposure During Pregnancy, Foetal Death, Premature Delivery
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Tixocortol Pivalate
Dosage: 2 gtt, 2x/day
Start date: 2008-10-31
End date: 2008-11-07
Imuran
Dosage: 0.5 df, 1x/day
Start date: 2008-09-06
End date: 2008-09-16
Neoral
Dosage: 100 mg, 2x/day
End date: 2008-10-21
Kayexalate
Dosage: unk
Start date: 2008-08-05
End date: 2008-11-15
Acetylcysteine
Dosage: unk
Start date: 2008-11-07
End date: 2008-11-10
Lasix
Dosage: 500 mg, 2x/day
Start date: 2008-06-13
End date: 2008-12-15
Folic Acid
Dosage: 5 mg, 2x/day
Start date: 2008-10-08
End date: 2008-12-17
Mucomyst
Dosage: 200 mg, 2x/day
Start date: 2008-11-07
End date: 2008-11-10
Cefpodoxime Proxetil
Dosage: 100 mg, 2x/day
Start date: 2008-11-07
End date: 2008-11-17
Rubozinc
Dosage: 15 mg, 1x/day
Start date: 2008-08-29
End date: 2008-09-16
Nexium
Dosage: 40 mg, 1x/day
Start date: 2008-06-13
End date: 2008-08-21
Atarax
Dosage: 25 mg, 1x/day
Start date: 2008-08-18
End date: 2008-12-17
Kayexalate
Dosage: unk
Start date: 2008-06-13
End date: 2008-08-04
Erythromycin
Dosage: unk
Start date: 2008-08-29
End date: 2008-09-16
UN-Alfa
Dosage: 0.5 ug, 1x/day
Start date: 2008-07-04
End date: 2008-10-17
Aranesp
Dosage: 60 ug, weekly
Start date: 2008-08-27
End date: 2008-09-28
Amlodipine Besylate
Dosage: 5 mg, 1x/day
Start date: 2008-06-20
End date: 2008-09-16
Neoral
Dosage: 25 mg, 2x/day
Start date: 2008-11-06
End date: 2008-12-17
Renagel
Dosage: 800 mg, 3x/day
Start date: 2008-08-28
End date: 2008-12-15
Isotretinoin
Dosage: unk
Start date: 2008-08-29
End date: 2008-09-16
Nexium
Dosage: 20 mg, 1x/day
Start date: 2008-08-22
End date: 2008-12-17
Amlodipine Besylate
Dosage: 10 mg, 1x/day
Start date: 2008-09-17
End date: 2008-12-15
Venofer
Dosage: 100 ug, tree time x week
Start date: 2008-10-17
End date: 2008-12-14
Venofer
Dosage: 100 ug, twice x week
Start date: 2008-12-15
End date: 2008-12-17
Imuran
Dosage: 1.5 df, 2x/day
Start date: 2008-06-13
End date: 2008-08-21
Neoral
Dosage: 50 mg, 2x/day
Start date: 2008-10-22
End date: 2008-11-05
Aranesp
Dosage: 80 ug, unk
Start date: 2008-09-29
End date: 2008-12-17
Imuran
Dosage: 1 df, 2x/day
Start date: 2008-08-22
End date: 2008-09-05
Venofer
Dosage: 100 ug, twice x week
Start date: 2008-06-13
End date: 2008-10-16
Possible Kayexalate side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-29
Patient: 34 year old female
Reactions: Stillbirth, Foetal Exposure During Pregnancy, Renal Graft Loss
Drug(s) suspected as cause:
Venofer
Dosage: 100 mg, qw2
Start date: 2008-12-15
End date: 2008-12-17
Neoral
Dosage: 50 mg, bid
Administration route: Oral
Start date: 2008-10-22
End date: 2008-11-05
Kayexalate
Dosage: 2 df, qd
Administration route: Oral
Start date: 2008-08-05
End date: 2008-11-15
Mucomyst
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2008-11-07
End date: 2008-11-10
Acetylcysteine
Dosage: 2 df, qd
Start date: 2008-11-07
End date: 2008-11-10
Cefpodoxime Proxetil
Dosage: 100 mg, bid
Administration route: Oral
Start date: 2008-11-07
End date: 2008-11-17
Erythromycin
Dosage: 1 df, bid
Administration route: Topical
Start date: 2008-08-29
End date: 2008-09-16
Lasix
Dosage: 500 mg, bid
Administration route: Oral
Start date: 2008-06-13
End date: 2008-12-15
Esomeprazole Sodium
Dosage: 40 mg, qd
Administration route: Oral
Start date: 2008-06-13
End date: 2008-08-21
Imuran
Dosage: 50 mg, bid
Administration route: Oral
Start date: 2008-08-22
End date: 2008-09-05
Atarax
Dosage: 25 mg, qd
Administration route: Oral
Start date: 2008-08-18
End date: 2008-12-17
Rubozinc
Dosage: 15 mg, qd
Administration route: Oral
Start date: 2008-08-29
End date: 2008-09-16
Neoral
Dosage: 100 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2008-08-01
End date: 2008-10-21
Neoral
Dosage: 25 mg, bid
Administration route: Oral
Start date: 2008-11-06
End date: 2008-12-17
Imuran
Dosage: 75 mg, bid
Administration route: Oral
Start date: 2008-06-13
End date: 2008-08-21
Kayexalate
Dosage: 1 df, qd
Administration route: Oral
Start date: 2008-06-13
End date: 2008-08-04
Venofer
Dosage: 100 mg, qw3
Start date: 2008-10-17
End date: 2008-12-14
Renagel
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2008-08-28
End date: 2008-12-15
Pivalone
Dosage: 2 drops bid
Start date: 2008-10-31
End date: 2008-11-07
Folic Acid
Dosage: 5 mg, bid
Administration route: Oral
Start date: 2008-10-08
End date: 2008-12-17
Esomeprazole Sodium
Dosage: 20 mg, qd
Administration route: Oral
Start date: 2008-08-22
End date: 2008-12-17
Aranesp
Dosage: 80 ug, qw2
Start date: 2008-09-29
End date: 2008-12-17
Imuran
Dosage: 25 mg, qd
Administration route: Oral
Start date: 2008-09-06
End date: 2008-09-16
Amlodipine Besylate
Dosage: 5 mg, qd
Administration route: Oral
Start date: 2008-06-20
End date: 2008-09-16
Isotretinoin
Dosage: 1 df, bid
Administration route: Topical
Start date: 2008-08-29
End date: 2008-09-16
Amlodipine Besylate
Dosage: 10 mg, qd
Administration route: Oral
Start date: 2008-09-17
End date: 2008-12-15
UN-Alfa
Dosage: 0.5 ug, qd
Administration route: Oral
Start date: 2008-07-04
End date: 2008-10-17
Aranesp
Dosage: 60 ug, qw
Start date: 2008-07-27
End date: 2008-09-28
Venofer
Dosage: 100 mg, qw2
Start date: 2008-06-13
End date: 2008-10-16
Possible Kayexalate side effects in 56 year old male
Reported by a pharmacist from Canada on 2012-02-16
Patient: 56 year old male
Reactions: Dyspnoea, Hyperkalaemia, Pain
Drug(s) suspected as cause:
Kayexalate
Other drugs received by patient: Furosemide; Atorvastatin; Amlodipine; Hydralazine HCL; Atenolol; Pantoprazole; Gliclazide
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-14
Patient: 53 year old male
Reactions: Leukocytoclastic Vasculitis, Renal Impairment, Sepsis, Anaemia, Dizziness, Hydrocephalus, Thrombocytopenia, Nephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Administration route: Oral
Start date: 2011-05-01
Keppra
Administration route: Oral
Ramipril
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Repaglinide
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Eupressyl
Administration route: Oral
Start date: 2011-05-29
Prednisolone
Administration route: Oral
Start date: 2011-06-05
End date: 2011-06-26
Calcium Carbonate
Administration route: Oral
Amlodipine Besylate
Administration route: Oral
Prednisolone
Administration route: Oral
Start date: 2011-06-30
Kayexalate
Administration route: Oral
Start date: 2011-06-03
End date: 2011-06-26
Citalopram
Dosage: 20
Administration route: Oral
Renagel
Administration route: Oral
Atorvastatin
Administration route: Oral
Start date: 2011-05-30
End date: 2011-06-24
Aranesp
Dosage: 50mug
Other drugs received by patient: Solu-Medrol; Solu-Medrol
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-06
Patient: 53 year old male
Reactions: Tubulointerstitial Nephritis, Renal Impairment, Sepsis, Dizziness, Hydrocephalus, Nephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amlodipine Besylate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Citalopram Base
Dosage: unk
Administration route: Oral
Kayexalate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-03
End date: 2011-06-26
Prednisolone
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-27
Prednisolone
Dosage: unk
Start date: 2011-06-30
Atorvastatin
Dosage: 10 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-24
Eupressyl
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Keppra
Dosage: unk
Administration route: Oral
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Ramipril
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Other drugs received by patient: Fucidine CAP; Methylprednisolone; Solu-Medrol; Locoid
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-06
Patient: 53 year old male
Reactions: Leukocytoclastic Vasculitis, Sepsis, Dizziness, Hydrocephalus, Nephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amlodipine Besylate
Administration route: Oral
Ramipril
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Prednisolone
Administration route: Oral
Start date: 2011-06-30
Atorvastatin
Administration route: Oral
Start date: 2011-05-30
End date: 2011-06-24
Keppra
Administration route: Oral
Kayexalate
Administration route: Oral
Start date: 2011-06-03
End date: 2011-06-26
Citalopram Hydrobromide
Administration route: Oral
Repaglinide
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Eupressyl
Administration route: Oral
Start date: 2011-05-29
Prednisolone
Administration route: Oral
Start date: 2011-06-05
End date: 2011-06-26
Other drugs received by patient: Solu-Medrol; Solu-Medrol
Possible Kayexalate side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-03
Patient:
Reactions: Renal Impairment, Anaemia, Sepsis, Hydrocephalus, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Eupressyl
Dosage: 30 mg, tid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Calciparine
Dosage: 0.2 ml, sc
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-08
End date: 2011-08-08
Aranesp
Dosage: 50 mcg, every 15 days
Indication: Product Used FOR Unknown Indication
Kayexalate
Dosage: 15 g, 3x/w
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-03
Citalopram Hydrobromide
Dosage: 20 mg/kg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Calcium Carbonate
Dosage: 1 unk, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Renagel
Dosage: 1 df, qd
Administration route: Oral
Indication: Hyperphosphataemia
Prednisone TAB
Dosage: 30 mg/kg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-01
Depakene
Dosage: 500 mg/kg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-16
Possible Kayexalate side effects in 53 year old male
Reported by a physician from France on 2012-02-03
Patient: 53 year old male
Reactions: Anaemia, Condition Aggravated, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aranesp
Dosage: 50 mug, q2wk
Indication: Product Used FOR Unknown Indication
Prednisone TAB
Dosage: 30 mg/kg, qd
Administration route: Oral
Start date: 2011-05-01
Keppra
Eupressyl
Dosage: 90 mg, qd
Administration route: Oral
Start date: 2011-05-29
Kayexalate
Dosage: 15 g, 3 times/wk
Administration route: Oral
Start date: 2011-06-03
Citalopram Hydrobromide
Dosage: 20 unk, unk
Administration route: Oral
Calcium Carbonate
Dosage: unk
Administration route: Oral
Renagel
Dosage: unk unk, qd
Administration route: Oral
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-02
Patient: 53 year old male
Reactions: Tubulointerstitial Nephritis, Renal Impairment, Dizziness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atorvastatin
Dosage: unk
Administration route: Oral
Start date: 2011-05-30
End date: 2011-06-14
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Eupressyl
Dosage: unk
Administration route: Oral
Start date: 2011-05-29
Keppra
Dosage: unk
Administration route: Oral
Amlodipine Besylate
Dosage: unk
Administration route: Oral
Prednisolone
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-27
Kayexalate
Dosage: unk
Administration route: Oral
Start date: 2011-06-03
End date: 2011-06-26
Citalopram
Dosage: unk
Administration route: Oral
Ramipril
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Other drugs received by patient: Fucidine CAP; Locoid; Solu-Medrol
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-01
Patient: 53 year old male
Reactions: Tubulointerstitial Nephritis, Renal Impairment, Sepsis, Dizziness, Hydrocephalus, Nephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kayexalate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-03
End date: 2011-06-26
Prednisolone
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-27
Prednisolone
Dosage: unk
Start date: 2011-06-30
Repaglinide
Dosage: unk
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2011-06-03
End date: 2011-06-26
Atorvastatin
Dosage: 10 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-30
End date: 2011-06-24
Eupressyl
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Amlodipine Besylate
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ramipril
Dosage: unk
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Keppra
Dosage: unk
Administration route: Oral
Citalopram Base
Dosage: unk
Administration route: Oral
Other drugs received by patient: Solu-Medrol; Fucidine CAP; Methylprednisolone; Locoid
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-01
Patient: 53 year old male
Reactions: Renal Failure, Anaemia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Calciparine
Dosage: parenteral injection
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-08
End date: 2011-08-08
Kayexalate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-03
Depakene
Dosage: extended release
Administration route: Oral
Indication: Epilepsy
Start date: 2011-07-16
Renagel
Dosage: daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Prednisone TAB
Dosage: daily
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-01
Aranesp
Indication: Product Used FOR Unknown Indication
Citalopram Hydrobromide
Dosage: daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Eupressyl
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-29
Calcium Carbonate
Dosage: daily
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Keppra
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-31
Patient: 53 year old male
Reactions: Tubulointerstitial Nephritis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Citalopram
Administration route: Oral
Kayexalate
Administration route: Oral
Start date: 2011-06-03
End date: 2011-06-26
Prednisolone
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-27
Keppra
Administration route: Oral
Eupressyl
Administration route: Oral
Start date: 2011-05-29
Ramipril
Administration route: Oral
Start date: 2011-06-04
End date: 2011-06-14
Repaglinide
Administration route: Oral
Start date: 2011-06-03
End date: 2011-06-26
Atorvastatin
Administration route: Oral
Start date: 2011-05-30
End date: 2011-06-14
Amlodipine Besylate
Administration route: Oral
Possible Kayexalate side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-27
Patient: 53 year old male
Reactions: Renal Failure, Anaemia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kayexalate
Administration route: Oral
Start date: 2011-06-03
Calcium Carbonate
Aranesp
Calciparine
Start date: 2011-07-08
End date: 2011-08-08
Eupressyl
Administration route: Oral
Start date: 2011-05-29
Prednisone TAB
Start date: 2011-05-01
Renagel
Administration route: Oral
Citalopram Hydrobromide
Administration route: Oral
Depakene
Administration route: Oral
Indication: Epilepsy
Start date: 2011-07-16
Other drugs received by patient: Keppra
Possible Kayexalate side effects in 56 year old male
Reported by a pharmacist from Canada on 2012-01-27
Patient: 56 year old male
Reactions: Dyspnoea, Hyperkalaemia, Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kayexalate
Other drugs received by patient: Pantoprazole; Furosemide; Hydralazine HCL; Atorvastatin; Gliclazide; Amlodipine; Atenolol
Possible Kayexalate side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-25
Patient: 65 year old female
Reactions: Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Drug Interaction, General Physical Health Deterioration, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Calcium Carbonate
Dosage: 4 df (2 df, in the morning and in the evening)
Indication: Product Used FOR Unknown Indication
Fucidine CAP
Dosage: 4 df (2 df, in the morning and in the evening)
Indication: Osteitis
Start date: 2011-05-01
End date: 2011-08-01
Cordarone
Indication: Cardiac Disorder
Start date: 2011-05-01
Levothyroxine Sodium
Indication: Thyroidectomy
Start date: 2010-01-01
Levofloxacin
Dosage: 0.5 df (0.5 df, in the morning)
Indication: Product Used FOR Unknown Indication
End date: 2011-08-01
Fosrenol
Dosage: 3 gm (1 gm, in the morning, midday, in the evening)
Indication: Product Used FOR Unknown Indication
Kayexalate
Dosage: (1 df, 4 in 1 wk) (punctually)
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-01
Other drugs received by patient: Lexomil (Bromazepam) (Bromazepam); Cardensiel (Bisoprolol Fumarate) (Bisoprolol Hemifumarate); Stablon (Tianeptine) (Tianeptine); Inipomp (Pantoprazole) (40 MG) (Pantoprazole); Furosemide; Clopidogrel; Tahor (Atorvastatin Calcium) (10 MG, Tablet) (Atorvastatin); Ixprim (Ultracet) (Tramadol, Paracetamol); Insulin; Procoralan (Ivabradine Hydrochloride) (5 MG) (Ivabradine)
|